M

🚀Metaculus Open-Source Rewrite is Live!

You're now enjoying a rewritten, open-source Metaculus, with a range of improvements and new opportunities for collaboration. Go here to learn more!

Question

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Total Forecasters25
Community Prediction43%

Make a Prediction

community: 43%
median 43.0%mean 41.4%
0%10%20%30%40%50%60%70%80%90%100%


Comments

? comments